---
title: "Jinhe Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 138 million yuan, an increase of 51.52%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250755811.md"
description: "According to the Zhitong Finance APP, Jinhe Biotechnology released its semi-annual report for 2025, showing an operating income of 1.39 billion yuan, a year-on-year increase of 30.45%. The net profit attributable to shareholders of the listed company was 138 million yuan, a year-on-year increase of 51.52%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 128 million yuan, a year-on-year increase of 50.88%. The basic earnings per share were 0.1787 yuan"
datetime: "2025-07-30T09:58:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250755811.md)
  - [en](https://longbridge.com/en/news/250755811.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250755811.md)
generator: "portal-rs"
---

# Jinhe Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 138 million yuan, an increase of 51.52%

According to the Zhitong Finance APP, Jinhe Biotechnology (002688.SZ) released its semi-annual report for 2025, reporting an operating income of 1.39 billion yuan, a year-on-year increase of 30.45%. The net profit attributable to shareholders of the listed company was 138 million yuan, a year-on-year increase of 51.52%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 128 million yuan, a year-on-year increase of 50.88%. The basic earnings per share were 0.1787 yuan

### Related Stocks

- [002688.CN](https://longbridge.com/en/quote/002688.CN.md)

## Related News & Research

- [U.S. job openings rise to 7.271 million in July](https://longbridge.com/en/news/297664395.md)
- [Beijing State-Owned Capital Operation targets “full-cycle, multi-asset” fund platform in 15th Five-Year plan draft](https://longbridge.com/en/news/297650698.md)
- [BW ESS buys 126-MW Spanish battery storage projects from Navacant](https://longbridge.com/en/news/297744603.md)
- [Motus FY26 earnings per share rise 19% to 1,753 cents; revenue climbs 1% to ZAR 113.55 billion](https://longbridge.com/en/news/297734398.md)
- [Xinhua Pharma unit Xincat’s azithromycin tablets pass China generic consistency evaluation](https://longbridge.com/en/news/297485179.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**